Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
PaperCitations, authors & open-access status
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,246 citations, 2019 year and closed oa status.
2,246
Citations
2019
Year
closed
OA Status